The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus....

Amwell, MDLive, Element Science, Carbon Health, AliveCor, El Camino, ATA, GSR Ventures This week we had the Future of Virtual Care main event....

The number of studies about COVID-19 has risen steeply from the start of the pandemic, from around 20,000 in early March...

Life sciences-focused venture capital firm Epidarex Capital has hit a £102m final close for its third fund.Epidarex Capital III UK will focus on building...

Proprio, the surgical navigation company ‘creating the most transformative technology in surgery since the X-ray’, has landed $23 million in series A...

GSR Ventures is focused on investing in artificial intelligence and digital healthcare Venture capital used to be a cottage industry, with...

Roundup Welcome to this week's roundup of AI-related news. The US military wants AI tech to help find a COVID-19 vaccine: The US Department...

The Base Camp facility of ElevateBio is 140,000 square feet in Waltham, Mass. for the support of gene and cell therapy startups. (ELEVATEBIO) By...

OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of...

Sponsored by: Scheduled for August 4, 2020, 10 am to 11 am REGISTER Cytometry is a core capability of many biology and immunology focussed groups in...

UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its artificial intelligence (AI) technology to guide drug discovery.  The...

American Psychiatry Association's head of Innovation Dr. Nina Vasan speaks with Bambi Roizen Bambi Francisco Roizen, Vator Founder, and CEO, speaks with Nina...